Boston blog main / Boston top stories / Boulder / Denver blog main / Denver top stories / Detroit blog main / Detroit top stories / Indiana blog main / Indiana top stories / National blog main / National top stories / New York blog main / New York top stories / Raleigh-Durham blog main / Raleigh-Durham top stories / San Diego blog main / San Diego top stories / San Francisco / San Francisco blog main / San Francisco top stories / Seattle blog main / Seattle top stories / Texas blog main / Texas top stories / Wisconsin blog main / Wisconsin top stories / Adaptive Insights / Allogene Therapeutics / Anaplan / Box / Data Analytics / deals / Del Monte / DFJ Growth / DocuSign / enterprise software / Entrepreneurship / Equillium / Eventbrite / financial planning and analysis software / Financing / funding / Granite Ventures / HP / IBM / initial public offering / innovation / Internet / Investor / IPO / IT / Kepion / Livent / McAfee / Meritech Capital Partners / oracle / Osmotica Pharmaceuticals / Premji Invest / SanFranciscoVC / sap / Shasta Ventures / Software / startups / Top Tier Capital Partners / United Airlines / Upwork / VC / Vena Solutions / Venture Capital / Web / Web-based Software / Workday

Anaplan Ups Estimate For Its IPO Haul; Allogene IPO Raises $288M

Posted on: Oct 11, 2018   |   Posted by: Biotech Mag

Anaplan Ups Estimate For Its IPO Haul; Allogene IPO Raises $288M

San Francisco-based Anaplan , one of five companies planning to close initial public offerings this week, raised the expected price range for its shares in an SEC filing...

Continue reading ...



Other Posts from Biotech Mag